Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440401
Status:
COMPLETED
Last Update Posted:
2012-05-08
First Post:
2007-02-26
Brief Title:
TachoSil Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery TC-023-IM
Sponsor:
Nycomed
Organization:
Nycomed
Study Overview
Official Title:
A Randomised Open Label Parallel-group Multi-centre Trial to Compare the Efficacy and Safety of TachoSil Versus Standard Haemostatic Treatment in Cardiovascular Surgery
Status:
COMPLETED
Status Verified Date:
2010-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate efficacy and safety of TachoSil in cardiovascular surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None